Wang Q, Jia W, Liu J, Zhao Q, Yang Z. Global, regional, and national burden of liver cancer due to alcohol use, 1990–2021: results from the global burden of disease study 2021. Eur J Gastroenterol Hepatol. 2025;37(4):466–76.

Article  PubMed  Google Scholar 

Danpanichkul P, Díaz LA, Suparan K, Tothanarungroj P, Sirimangklanurak S, Auttapracha T, et al. Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021. Clin Mol Hepatol. 2025;31(2):525–47.

Article  PubMed  PubMed Central  Google Scholar 

Danpanichkul P, Duangsonk K, Tham EKJ, Tothanarungroj P, Auttapracha T, Prasitsumrit V, et al. Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United states: 2000 to 2021. Alcohol Clin Exp Res. 2025;49(2):368–78.

Article  Google Scholar 

Danpanichkul P, Pang Y, Diaz LA, Arab JP, Hwang SY, Dejvajara D, et al. Young adults and alcohol-associated liver cancer: incidence and death from 2000 to 2021. Cancers (Basel). 2025;17(4):609.

Article  CAS  PubMed  Google Scholar 

Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology. 2018;155(6):1828–e18372.

Article  PubMed  Google Scholar 

Yang T, Lei Y, Liao L, Xie C, Mo X, Cai D, et al. Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990–2021: a multi-model trend analysis and forecasting study. Hepatol Int. 2025;19(3):619–32.

Article  PubMed  Google Scholar 

Gu Y, Guo C, Liu Z, Zhang Y, Han X, Zhang X, et al. The trend in incidence of non-alcoholic fatty liver disease and its impact on cirrhosis and liver cancer: an analysis from global burden of disease 2021. Public Health. 2025;242:79–86.

Article  PubMed  Google Scholar 

He F, Sha Y, Wang B. Relationship between alcohol consumption and the risks of liver cancer, esophageal cancer, and gastric cancer in China: meta-analysis based on case-control studies. Medicine. 2021;100(33):e26982.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turati F, Galeone C, Rota M, Pelucchi C, Negri E, Bagnardi V, et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2014;25(8):1526–35.

Article  CAS  PubMed  Google Scholar 

Chuang SC, Lee YC, Wu GJ, Straif K, Hashibe M. Alcohol consumption and liver cancer risk: a meta-analysis. Cancer Causes Control. 2015;26(9):1205–31.

PubMed  Google Scholar 

McKillop IH, Schrum LW, Alcohol. Alcohol Liver Cancer. 2005;35(3):195–203.

CAS  Google Scholar 

Grewal P, Viswanathen VA. Liver cancer and alcohol. Clin Liver Dis. 2012;16(4):839–50.

Article  PubMed  Google Scholar 

Liu T, Zhang F, Feng Y, Han P, Gao Y. Alcohol-metabolizing enzymes, liver diseases and cancer. Semin Liver Dis. 2025;45(1):99–113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heckley GA, Jarl J, Asamoah BO, G-Gerdtham U. How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer. 2011;11:446.

Article  PubMed  PubMed Central  Google Scholar 

Kim GA, Lee HC, Choe J, Kim MJ, Lee MJ, Chang HS et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017:S0168-8278(17)32294-8.

Petrelli F, Manara M, Colombo S, De Santi G, Ghidini M, Mariani M, et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and steatosis or steatohepatitis. Neoplasia. 2022;30:100809.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orci LA, Sanduzzi-Zamparelli M, Caballol B, Sapena V, Colucci N, Torres F, et al. Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review, meta-analysis, and meta-regression. Clin Gastroenterol Hepatol. 2022;20(2):283–e29210.

Article  PubMed  Google Scholar 

Ge XJ, Du YX, Zheng LM, Wang M, Jiang JY. Mortality trends of liver cancer among patients with type 2 diabetes at the global and national level. J Diabetes Complications. 2020;34(8):107612.

Article  PubMed  Google Scholar 

Pang Y, Kartsonaki C, Turnbull I, Guo Y, Clarke R, Chen Y, et al. Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people. Hepatology. 2018;68(4):1308–18.

Article  CAS  PubMed  Google Scholar 

Ho NT, Abe SK, Rahman MS, Islam R, Saito E, Gupta PC, et al. Diabetes is associated with increased liver cancer incidence and mortality in adults: a report from Asia cohort consortium. Int J Cancer. 2024;155(5):854–70.

Article  CAS  PubMed  Google Scholar 

Onikanni SA, Lawal B, Bakare OS, Ajiboye BO, Ojo OA, Farasani A, et al. Cancer of the liver and its relationship with diabetes mellitus. Technol Cancer Res Treat. 2022;21:15330338221119743.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2022;71(1):156–62.

Article  PubMed  Google Scholar 

Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680.

Article  PubMed  PubMed Central  Google Scholar 

Fabrizi F, Cerutti R, Alfieri CM, Ridruejo E. An update on hepatocellular carcinoma in chronic kidney disease. Cancers (Basel). 2021;13(14):3617.

Article  CAS  PubMed  Google Scholar 

Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Cancer in patients on Dialysis for end-stage renal renal disease: an international collaborative study. Lancet. 1999;354(9173):93–9.

Article  CAS  PubMed  Google Scholar 

Kanbay M, Bulbul MC, Copur S, Afsar B, Sag AA, Siriopol D, et al. Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease. J Nephrol. 2021;34(3):649–59.

Article  CAS  PubMed  Google Scholar